KAT-101 in Subjects With Hepatocellular Carcinoma (HCC)
NCT05603572
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
SUSPENDED
Status
148
Enrollment
INDUSTRY
Sponsor class
Stopped
Enrollment paused
Conditions
Hepatocellular Carcinoma
Fibrolamellar Carcinoma
Interventions
DRUG:
KAT-101
DRUG:
KAT-201
Sponsor
Primocure Pharma